July 10, also known as 710 or Oil Day, is the cannabis industry’s second annual “holiday.” Although not as popular or as well celebrated as 4/20, July 10 has picked up steam in recent years thanks to the rising popularity of concentrated cannabis products.
Sales data from various markets show that as sales continue to grow across markets and flower continues to dominate the product category lists, concentrates are one of, if not the fastest-growing, product segment.
The Colorado Marijuana Enforcement Division’s (MED) 2019 annual report noted 40,229 pounds of concentrate products were sold across both the medical and adult-use markets that year, up nearly 128% from 2016 when 17,647 pounds of concentrate products were sold. In comparison, in 2019, 350,429 pounds of flower products were sold across both the adult-use and medical markets, compared to 335,640 pounds of flower in 2016, an increase of only 4.4%.
In Massachusetts, a newer adult-use market, flower remains the top-selling and fastest-growing segment, although concentrates continue to show steady growth. In June 2019, nearly $19.3 million worth of dried cannabis flower and $12.9 million of concentrates were sold. In June 2020, more than $26.6 million worth of flower and just under $14.1 million worth of concentrates were sold, an increase of 38% and 17%, respectively. (Massachusetts’ market also was affected by a temporary mandatory shutdown of all adult-use sites in a statewide COVID-19 related stay-at-home order.)
Cannabis extract sales also have been booming in Canada since extracts were legally allowed to be sold starting in October 2019. That month, 320,201 units of concentrate products were sold on the non-medical market according to Health Canada data. In April 2020, the most recently reported month, 813,972 units were sold in the adult-use market, an increase of 154%. In that same time, flower sales have decreased slightly from 5,204,955 packaged units to 5,199,858.
Building a National Concentrate Brand
Certain cannabis concentrate companies have been able to ride this wave, growing from niche product manufacturers to national brands. Select, with its recent acquisition by multi-state operator Curaleaf, is one such company. After establishing itself in the cannabis marketplace with its cotton wick cartridge in Oregon in 2015, Select is now sold in California, Nevada, Arizona, Colorado, Michigan, Maryland, Oklahoma and Connecticut, according to Cameron Forni, the president and co-founder of Select.
Since founding the company, Forni has seen the cannabis consumer evolve on concentrates.
“What we've seen over the past five years among consumers is an evolution in appreciation for hardware and oil quality,” Forni wrote to Cannabis Business Times in a statement. “Across the industry there has been an evolution of terpene usage and formulations.”
Select Elite Live, a concentrate product that combines THC oil with high-terpene extract (HTE), saw first day sales double that of other Standard Elite products, Forni says. “This tells us that customers are excited about terpene innovation, not just THC potency.”
He confirms that concentrate sales spike on Oil Day, but notes that concentrates are especially popular on 4/20. “Vape pens and concentrates have experienced doubled or nearly doubled sales around holidays like 4/20, negating the theory that holiday shoppers tend to prefer flower,” he says.
While increasing in popularity, Forni says sales data shows that concentrates are mostly popular with a small subset of super-enthusiasts. “In looking at sales data from 7/10, we have observed that the general uptick in concentrate sales specifically is driven by a smaller, but growing and enthusiastic group of dabbers.”
Curaleaf Explains Its Purchase
For Joe Lusardi, Curaleaf’s CEO, the decision to acquire Select in February 2020 came down to tapping into a market that it had yet to really dig into. “Select was an attractive prospect for us as the highest revenue generating wholesaler in the U.S., and the leading lifestyle brand on the west coast with an incredibly talented management team behind it,” Lusardi said in a statement to Cannabis Business Times.
“We believe it was a good time for us to further build our adult-use offer and increase our presence on the West Coast—which we think will pay off as more states look to cannabis legalization for tax revenue and job creation in the wake of COVID-19,” he added.
Lusardi also noted the increased ability Curaleaf now has to conduct R&D with an experienced concentrate manufacturer, something that is of interest to a company trying to appeal to as broad a range of consumers as possible.
“Our mission as a business is to increase confidence in cannabis consumption and make it accessible for everyone—from the first-time user to the cannabis connoisseur, people using cannabis for a variety of health and wellness needs through to those choosing it as an alternative to a glass of wine,” Lusardi said. “Through our integration of the Select business we’re developing a premier R&D offering to look into new form factors and product development.”
Schwazze, formerly operating as Medicine Man Technologies, Inc., a vertically-integrated Colorado cannabis company, today provided a business update. Specifically, the company shared the pro forma financial results that reflect the acquisition of Mesa Organics, which closed on April 20, 2020, and announced the termination of previously named term sheets including “the Dabble Term Sheet” with Cold Baked, LLC and Golden Works, LLC, the “Los Sueños Term Sheet” with Los Suenos, LLC and Emerald Fields Grow, LLC, and the “Farm Boy Term Sheet” (as part of the Los Sueños Farm acquisition) with Farm Boy, LLC and Baseball 18, LLC.
Pro Forma Financial Results Including Acquisition of Mesa Organics
The company provided unaudited condensed combined pro forma financial results for the first three months of 2020, the full year 2019, and balance sheet as of March 31, 2020. These financial results reflect the acquisition of Mesa Organics, which closed on April 20, 2020. The company believes that providing the pro forma results will enable shareholders to evaluate its ongoing performance more accurately.
Nancy Huber, Chief Financial Officer of Schwazze said, "We are excited to have Mesa Organics and the extraction and manufacturing business, Purplebee’s, as a cornerstone in the vertically integrated platform we are building in Colorado. In the pro forma 2019 Income Statement, Mesa Organics was accretive to Schwazze by $0.09 cents per share, and we believe this business will continue to be accretive to our overall platform. Additionally, since the closing of the acquisition, we have made significant progress in integrating the Mesa Organics and Purplebee’s operations. We are excited about the opportunity ahead and look forward to sharing our results going forward.”
The unaudited condensed combined pro forma results including standalone Schwazze and Mesa Organics historical results, and explanatory notes were included in a Form 8-K/A filed with the U.S. Securities and Exchange Commission on July 2, 2020.
Acquisition Strategy Update
Schwazze terminated the binding term sheets for two announced acquisitions with Dabble Extracts, a cannabis concentrates company, and Los Sueños Farms, an outdoor and greenhouse cannabis cultivator. Following the signing of Colorado House Bill 19-1090, the Company quickly moved forward on numerous term sheets with Colorado cannabis operators with limited due diligence completed. However, throughout the Company’s rigorous M&A process, key business and valuation issues were identified and as such, the Company decided to no longer pursue the acquisitions of Dabble and Los Sueños Farms.
Justin Dye, Chairman and Chief Executive Officer of Schwazze shared, “We know that continuing to focus on shareholder return is the right thing to do at this time. Our Board believes that it is in our best interest to build a differentiated business in Colorado. Additionally, we remain confident in our ability to grow organically and through future merger and acquisition opportunities. We have a strong M&A and real estate growth plan and infrastructure to provide us a pipeline of opportunities in the marketplace.”
The company reiterated its commitment to establishing a leading vertically integrated platform in the cannabis space. With a proven leadership team comprised of Fortune 500 executives and cannabis experts, the company will continue to make decisions that uniquely position Schwazze to provide the most trusted products and experiences for consumers. The company remains in negotiations with the following announced acquisitions, Roots Rx, Medicine Man, MedPharm, Canyon Cultivation, and Medically Correct.
For more information about Schwazze, please visit https://www.Schwazze.com/.
科罗拉多州大麻执法部（ MED ）2019年年度报告指出，当年在医疗和成人使用市场上销售了40229磅浓缩产品，比2016年销售17647磅浓缩产品时增长了近128%。相比之下，2019年，成人和医疗市场的花卉产品销量为350,429磅，而2016年为335,640磅，增幅仅为4.4%。
某些大麻浓缩公司已经能够驾驭这股浪潮，从利基产品制造商发展到国家品牌。Select 是一家这样的公司，最近被多国运营商 Curaleaf 收购。Select 总裁兼联合创始人卡梅隆•福尼( Cameron Forni )表示， Select 在2015年在俄勒冈的大麻市场建立了自己的业务之后，现已在加利福尼亚州、内华达州、亚利桑那州、科罗拉多州、密歇根州、马里兰州、俄克拉荷马州和康涅狄格州销售。
Forni 在一份声明中向《坎纳比斯商业时报》( Cannabis Business Times )表示：“过去5年，我们在消费者中看到的是，对硬件和石油质量的升值正在演变。”“整个行业都出现了萜烯使用和配方的演变。”
Forni 说，选择 Elite Live ，这是一种将 THC 油和高萜提取物（ HTE ）结合起来的浓缩产品，第一天的销售额是其他标准 Elite 产品的两倍。“这告诉我们，客户对萜烯创新感到兴奋，而不仅仅是 THC 效力。”
他证实，集中销售在油日飙升，但他指出，集中是特别受欢迎的4/20。“像4/20这样的假期， Vape 笔和精矿的销售额翻了一番，几乎翻了一番，否定了假日购物者更喜欢花的理论，”他说。
对于 Curaleaf 首席执行官乔•卢扎迪( Joe Lusardi )来说，在2020年2月收购 Select 的决定，是为了打入一个尚未真正涉足的市场。“ Select 对我们来说是一个极具吸引力的前景，因为它是美国收入最高的批发商，也是西海岸领先的生活方式品牌，背后有一支非常优秀的管理团队，” Lusardi 在《坎纳比斯商业时报》的一份声明中表示。
Lusardi 还指出， Curaleaf 现在必须与一家经验丰富的浓缩制造商进行研发，这是一家试图吸引尽可能多的消费者的公司感兴趣的事情。
“作为一家企业，我们的使命是增强人们对大麻消费的信心，让每个人都能接触到大麻——从第一次使用大麻的专家到大麻鉴赏家，人们使用大麻来满足各种健康和健康需求，通过选择大麻作为一杯葡萄酒的替代品的人。”“通过我们对 Select 业务的整合，我们正在开发一个一流的研发产品，以研究新的形式因素和产品开发。”
Schwarzze 以前是一家名为 MedicineManTechnologies , Inc .的垂直一体化科罗拉多大麻公司，今天提供了一个业务更新。具体而言，公司与 Cold Baked , LLC 和 Golden Works , LLC 共同分享了反映收购 Mesa Organics 的备考财务业绩， Mesa Organics 于2020年4月20日完成收购，并宣布终止先前命名的条款清单，包括与 Cold Baked , LLC 和 Golden Works , LLC 的“ Dabble Term Sheet ”， Los Sue ñ os Term Sheet 与 Los Suenos , LLC 和 Emerald Fields Grow 的“ Los Sue ñ os Term Sheet ”。LLC 和“ Farm Boy Term Sheet ”（作为 Los Su ñ os Farm 收购的一部分）与 Farm Boy , LLC 和 Baseball 18, LLC 。
备考财务业绩包括收购 Mesa Organics
公司提供了未经审计的截至2020年前三个月、2019年全年、截至2020年3月31日的资产负债表的简明合并备考财务业绩。这些财务业绩反映了 Mesa Organics 的收购，该收购于2020年4月20日完成。公司认为，提供备考业绩将使股东能够更加准确地评估其持续经营业绩。
Schwarzze 首席财务官 Nancy Huber 说：“我们很高兴 Mesa Organics 和 Purplebee 的提取和制造业务成为我们在科罗拉多州建立的垂直集成平台的基石。在备考2019年损益表中， Mesa Organics 对 Schwarzze 的每股增值0.09美元，我们相信该业务将继续为我们的整体平台增值。此外，收购完成后，我们在整合 Mesa Organics 和 Purplebee 的业务方面取得了重大进展。我们对未来的机遇感到兴奋，并期待着分享我们未来的成果。”
未经审核简明综合备考业绩包括独立 Schwarzze 及 Mesa Organics 历史业绩，以及附注已包括于2020年7月2日向美国证券交易委员会提交的表格8-K / A 。
Schwarzze 终止了与大麻浓缩公司 Dabble Extracts 和户外和温室大麻栽培公司 Los Sue ñ os Farms 两家公司的合并条款。在签署了《科罗拉多众议院法案》19-1090之后，该公司迅速向科罗拉多州大麻经营者提交了许多条款清单，完成了有限的尽职调查。然而，在整个公司严格的并购过程中，确定了关键的业务和估值问题，因此，公司决定不再收购 Dabble 和 Los Sue ñ os Farms 。
Schwarzze 董事长兼首席执行官贾斯汀•戴尔( Justin Dye )表示：“我们知道，继续关注股东回报是目前正确的做法。我们的董事会认为，在科罗拉多州建立差异化的业务符合我们的最大利益。此外，我们仍对我们通过未来并购机会实现有机增长的能力充满信心。我们拥有强大的并购和房地产增长计划和基础设施，为我们提供市场机遇。”
该公司重申了在大麻领域建立领先的垂直一体化平台的承诺。凭借由《财富》500强企业高管和大麻专家组成的成熟领导团队，公司将继续做出独特定位的决策，为消费者提供最值得信赖的产品和体验。公司仍在与以下公告的收购， RootsRx ， MedicalMan ， MedPharm ， Canyon Cultivativation ， MedicalCorrect 进行谈判。
有关 Schwarzze 的更多信息，请访问 https://www.Schwarzze.com/。